Structured evidence table for Resveratrol Cognitive Performance Randomized Trial, generated from 1 reusable source document in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Resveratrol Cognitive Performance Randomized Trial | Dietary patterns have emerged as modifiable risk factors that may influence disease onset and progression. | 4 | Fekete M (2025) | Mediterranean Diet, Polyphenols, and Neuroprotection: Mechanistic Insights into Resveratrol and Oleuropein. |
| Resveratrol Cognitive Performance Randomized Trial | The Mediterranean diet (MedDiet), rich in fruits, vegetables, whole grains, legumes, fish, and extra virgin olive oil, has been consistently associated with better cognitive outcomes and reduced risk of neurodegeneration. | 4 | Fekete M (2025) | Mediterranean Diet, Polyphenols, and Neuroprotection: Mechanistic Insights into Resveratrol and Oleuropein. |
| Resveratrol Cognitive Performance Randomized Trial | Aim: This narrative review summarizes current evidence on the role of the MedDiet in slowing the progression of neurodegenerative diseases, with a particular focus on polyphenols such as resveratrol and oleuropein as key bioactive mediators. | 4 | Fekete M (2025) | Mediterranean Diet, Polyphenols, and Neuroprotection: Mechanistic Insights into Resveratrol and Oleuropein. |
| Resveratrol Cognitive Performance Randomized Trial | Background: Neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease, are among the leading causes of disability and mortality worldwide. | 4 | Fekete M (2025) | Mediterranean Diet, Polyphenols, and Neuroprotection: Mechanistic Insights into Resveratrol and Oleuropein. |
Source documents